MX2012001814A - Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso. - Google Patents

Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso.

Info

Publication number
MX2012001814A
MX2012001814A MX2012001814A MX2012001814A MX2012001814A MX 2012001814 A MX2012001814 A MX 2012001814A MX 2012001814 A MX2012001814 A MX 2012001814A MX 2012001814 A MX2012001814 A MX 2012001814A MX 2012001814 A MX2012001814 A MX 2012001814A
Authority
MX
Mexico
Prior art keywords
neuro
aminopyridine
cognitive
patient
psychiatric
Prior art date
Application number
MX2012001814A
Other languages
English (en)
Spanish (es)
Inventor
Thomas C Wessel
Andrew Blight
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of MX2012001814A publication Critical patent/MX2012001814A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2012001814A 2009-08-11 2010-08-11 Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso. MX2012001814A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23306909P 2009-08-11 2009-08-11
US23307709P 2009-08-11 2009-08-11
US23987709P 2009-09-04 2009-09-04
PCT/US2010/045211 WO2011019845A1 (en) 2009-08-11 2010-08-11 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions

Publications (1)

Publication Number Publication Date
MX2012001814A true MX2012001814A (es) 2012-06-01

Family

ID=43586462

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001814A MX2012001814A (es) 2009-08-11 2010-08-11 Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso.

Country Status (18)

Country Link
US (8) US20130053420A1 (zh)
EP (1) EP2464229B1 (zh)
JP (2) JP6137833B2 (zh)
KR (2) KR20120050473A (zh)
CN (1) CN102143687B (zh)
AR (1) AR077858A1 (zh)
AU (1) AU2010282509B2 (zh)
BR (1) BRPI1003991A2 (zh)
CA (1) CA2770698C (zh)
ES (1) ES2563751T3 (zh)
HK (1) HK1173911A1 (zh)
JO (1) JO3348B1 (zh)
MX (1) MX2012001814A (zh)
RU (1) RU2563821C2 (zh)
TW (2) TW201613585A (zh)
UY (1) UY32837A (zh)
WO (1) WO2011019845A1 (zh)
ZA (1) ZA201201001B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
US20130184316A1 (en) * 2010-07-15 2013-07-18 Andrew Hornstein Methods for diagnosing and treating concussive disorders
BR112013019265A2 (pt) * 2011-01-28 2016-10-11 Acorda Therapeutics Inc uso de bloqueadores do canal de potássio no tratamento da paralisia cerebral
US10793893B2 (en) 2011-06-30 2020-10-06 Serb Sa Methods of administering 3,4-diaminopyridine
US10905663B2 (en) 2013-03-05 2021-02-02 The University Of Chicago Treatment of demyelinating disorders
US20160058743A1 (en) * 2013-04-15 2016-03-03 Acorda Therapeutics, Inc. Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines
DE102014221687B4 (de) * 2014-10-24 2019-07-04 Danfoss Silicon Power Gmbh Leistungshalbleitermodul mit kurzschluss-ausfallmodus
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5977131A (en) 1997-04-09 1999-11-02 Pfizer Inc. Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
WO2002072025A2 (en) * 2001-03-14 2002-09-19 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services Improving postsynaptic response by a combination of 4-minopyridine and agonist
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) * 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions

Also Published As

Publication number Publication date
KR20170128633A (ko) 2017-11-22
US20180147193A1 (en) 2018-05-31
EP2464229A4 (en) 2013-02-13
TW201613585A (en) 2016-04-16
US20190015399A1 (en) 2019-01-17
BRPI1003991A2 (pt) 2015-09-15
KR20120050473A (ko) 2012-05-18
US20200113882A1 (en) 2020-04-16
WO2011019845A1 (en) 2011-02-17
AU2010282509A1 (en) 2012-03-01
RU2012108656A (ru) 2013-09-20
RU2563821C2 (ru) 2015-09-20
JP6137833B2 (ja) 2017-05-31
US20130053420A1 (en) 2013-02-28
UY32837A (es) 2011-03-31
ZA201201001B (en) 2014-10-29
US20170281608A1 (en) 2017-10-05
CN102143687A (zh) 2011-08-03
CA2770698A1 (en) 2011-02-17
ES2563751T3 (es) 2016-03-16
EP2464229A1 (en) 2012-06-20
AU2010282509B2 (en) 2015-07-30
TWI549678B (zh) 2016-09-21
JO3348B1 (ar) 2019-03-13
US20190247379A1 (en) 2019-08-15
HK1173911A1 (zh) 2013-05-31
AR077858A1 (es) 2011-09-28
CA2770698C (en) 2018-01-30
TW201110967A (en) 2011-04-01
JP2016074728A (ja) 2016-05-12
CN102143687B (zh) 2015-11-25
US20160213661A1 (en) 2016-07-28
US20170056385A1 (en) 2017-03-02
JP2013501805A (ja) 2013-01-17
EP2464229B1 (en) 2015-11-25

Similar Documents

Publication Publication Date Title
US20200113882A1 (en) Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
US20200113883A1 (en) Durable treatment with 4-aminopyridine in patients with demyelination
US20130330277A1 (en) Methods of using sustained release aminopyridine compositions
CN115776894A (zh) T型钙通道调节剂的使用方法
KR20150067168A (ko) 기억력 증진용 향정신성 조성물
TW202131910A (zh) 使用mtorc1調節劑的治療方法
IL230174A (en) Pharmaceutical composition for the treatment of premature ejaculation

Legal Events

Date Code Title Description
FG Grant or registration